One of the most maddening problems I’ve been encountering lately are shortages of common Generic medications. The most recent and hard-hitting one has been the unavailability of generic Maxzide and Dyazide (triamterene/hydrochlorothiazide ). For the Maxzide version, this is only true of the 37.5/25 mg tablets. The release date is somewhere between late April and late May of 2011, though there is no explanation given for this shortage. In my practice, the “fix” is to obtain a new order from prescribers for triamterene/hydrochlorthiazide (abbreviated HCTZ) in the 75/50 mg strength and have patients split them in half to obtain the correct dose. This shortage comes on the heels of another shortage of generic Medrol dosepacks (methylprednisolone), and generic Adderall. While the methylprednisolone problem seems to have quickly resolved, generic Adderall (amphetamine mixed salts) has been ongoing for months. Am I the only one who is wondering what has happened to our prescription drug supply chain? Please post a comment if you have any answers. A bulletin on the ASHP website is about the only thing I can find regarding the triamterene/hydrochlorothiazide shortage.
- “Drug Shortage Keeping Parents From Stupefying Their Kids” and related posts (holycoast.blogspot.com)
- Drug Shortages Continue – UCLA Spends 2 Hours A Day Checking on Cancer Drug Availability – ASHP Website Lists All Current Shortages (ducknetweb.blogspot.com)
- Early drug shortage warnings in the works (troyrecord.com)